{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:32:23Z","timestamp":1787956343797,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T00:00:00Z","timestamp":1463097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10549-016-3827-7","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T14:58:58Z","timestamp":1463151538000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy"],"prefix":"10.1007","volume":"157","author":[{"given":"Elisabeth","family":"Sulaica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raksha","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana V.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Niravath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,13]]},"reference":[{"key":"3827_CR1","unstructured":"Breast Cancer Facts & Figures\u00a02015\u20132016. American Cancer Society. http:\/\/www.cancer.org\/research\/cancerfactsstatistics\/breast-cancer-facts-figures . Accessed 16 Nov 2015"},{"issue":"10","key":"3827_CR2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1200\/JCO.1984.2.10.1102","volume":"2","author":"GM Clark","year":"1984","unstructured":"Clark GM, Osborne CK, McGuire WL (1984) Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 2(10):1102\u20131109","journal-title":"J Clin Oncol"},{"issue":"1","key":"3827_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","volume":"9","author":"T Arimidex","year":"2008","unstructured":"Arimidex T, Aoi CTG, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9(1):45\u201353. doi: 10.1016\/S1470-2045(07)70385-6","journal-title":"Lancet Oncol"},{"issue":"5","key":"3827_CR4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.GME.0000117061.40493.AB","volume":"11","author":"C Crandall","year":"2004","unstructured":"Crandall C, Petersen L, Ganz PA, Greendale GA (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause 11(5):519\u2013530","journal-title":"Menopause"},{"issue":"1","key":"3827_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-007-9580-1","volume":"108","author":"J Yoon","year":"2008","unstructured":"Yoon J, Malin JL, Tisnado DM, Tao ML, Adams JL, Timmer MJ, Ganz PA, Kahn KL (2008) Symptom management after breast cancer treatment: is it influenced by patient characteristics? Breast Cancer Res Treat 108(1):69\u201377. doi: 10.1007\/s10549-007-9580-1","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3827_CR6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.2007.11.5451","volume":"26","author":"AH Partridge","year":"2008","unstructured":"Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26(4):556\u2013562. doi: 10.1200\/JCO.2007.11.5451","journal-title":"J Clin Oncol"},{"issue":"11","key":"3827_CR7","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","volume":"100","author":"CA Stuenkel","year":"2015","unstructured":"Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ (2015) Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(11):3975\u20134011. doi: 10.1210\/jc.2015-2236","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3827_CR8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","volume":"124","author":"DD Rahn","year":"2014","unstructured":"Rahn DD, Carberry C, Sanses TV, Mamik MM, Ward RM, Meriwether KV, Olivera CK, Abed H, Balk EM, Murphy M, Society of Gynecologic Surgeons Systematic Review G (2014) Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol 124(6):1147\u20131156. doi: 10.1097\/AOG.0000000000000526","journal-title":"Obstet Gynecol"},{"issue":"1","key":"3827_CR9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.25314","volume":"128","author":"K Bakken","year":"2011","unstructured":"Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, Fabre A, Hemon B, Rinaldi S, Chajes V, Slimani N, Allen NE, Reeves GK, Bingham S, Khaw KT, Olsen A, Tjonneland A, Rodriguez L, Sanchez MJ, Etxezarreta PA, Ardanaz E, Tormo MJ, Peeters PH, van Gils CH, Steffen A, Schulz M, Chang-Claude J, Kaaks R, Tumino R, Gallo V, Norat T, Riboli E, Panico S, Masala G, Gonzalez CA, Berrino F (2011) Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer 128(1):144\u2013156. doi: 10.1002\/ijc.25314","journal-title":"Int J Cancer"},{"issue":"13","key":"3827_CR10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","volume":"310","author":"JE Manson","year":"2013","unstructured":"Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O\u2019Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB (2013) Menopausal hormone therapy and health outcomes during the intervention and extended post stopping phases of the Women\u2019s Health Initiative randomized trials. JAMA 310(13):1353\u20131368. doi: 10.1001\/jama.2013.278040","journal-title":"JAMA"},{"issue":"7","key":"3827_CR11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","volume":"97","author":"E Schoultz von","year":"2005","unstructured":"von Schoultz E, Rutqvist LE, Stockholm Breast Cancer Study G (2005) Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. J Natl Cancer Inst 97(7):533\u2013535. doi: 10.1093\/jnci\/dji071","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"3827_CR12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","volume":"100","author":"L Holmberg","year":"2008","unstructured":"Holmberg L, Iversen OE, Rudenstam CM, Hammar M, Kumpulainen E, Jaskiewicz J, Jassem J, Dobaczewska D, Fjosne HE, Peralta O, Arriagada R, Holmqvist M, Maenpaa J, Group HS (2008) Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 100(7):475\u2013482. doi: 10.1093\/jnci\/djn058","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"3827_CR13","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1200\/JCO.2013.53.9411","volume":"32","author":"EJ Folkerd","year":"2014","unstructured":"Folkerd EJ, Lonning PE, Dowsett M (2014) Interpreting plasma estrogen levels in breast cancer: caution needed. J Clin Oncol 32(14):1396\u20131400. doi: 10.1200\/JCO.2013.53.9411","journal-title":"J Clin Oncol"},{"issue":"3","key":"3827_CR14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1373\/clinchem.2013.213363","volume":"60","author":"DJ Handelsman","year":"2014","unstructured":"Handelsman DJ, Newman JD, Jimenez M, McLachlan R, Sartorius G, Jones GR (2014) Performance of direct estradiol immunoassays with human male serum samples. Clin Chem 60(3):510\u2013517. doi: 10.1373\/clinchem.2013.213363","journal-title":"Clin Chem"},{"issue":"1","key":"3827_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/EJE-07-0403","volume":"158","author":"C Ankarberg-Lindgren","year":"2008","unstructured":"Ankarberg-Lindgren C, Norjavaara E (2008) A purification step prior to commercial sensitive immunoassay is necessary to achieve clinical usefulness when quantifying serum 17beta-estradiol in prepubertal children. Eur J Endocrinol 158(1):117\u2013124. doi: 10.1530\/EJE-07-0403","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"3827_CR16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.steroids.2007.05.003","volume":"72","author":"RJ Santen","year":"2007","unstructured":"Santen RJ, Demers L, Ohorodnik S, Settlage J, Langecker P, Blanchett D, Goss PE, Wang S (2007) Superiority of gas chromatography\/tandem mass spectrometry assay (GC\/MS\/MS) for estradiol for monitoring of aromatase inhibitor therapy. Steroids 72(8):666\u2013671. doi: 10.1016\/j.steroids.2007.05.003","journal-title":"Steroids"},{"issue":"1","key":"3827_CR17","first-page":"5","volume":"32","author":"SK Grebe","year":"2011","unstructured":"Grebe SK, Singh RJ (2011) LC-MS\/MS in the clinical laboratory\u2014where to from here? Clin Biochem Rev 32(1):5\u201331","journal-title":"Clin Biochem Rev"},{"key":"3827_CR18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.talanta.2015.05.004","volume":"143","author":"W Gao","year":"2015","unstructured":"Gao W, Stalder T, Kirschbaum C (2015) Quantitative analysis of estradiol and six other steroid hormones in human saliva using a high throughput liquid chromatography-tandem mass spectrometry assay. Talanta 143:353\u2013358. doi: 10.1016\/j.talanta.2015.05.004","journal-title":"Talanta"},{"issue":"1","key":"3827_CR19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1055-9965.EPI-09-0643","volume":"19","author":"JM Faupel-Badger","year":"2010","unstructured":"Faupel-Badger JM, Fuhrman BJ, Xu X, Falk RT, Keefer LK, Veenstra TD, Hoover RN, Ziegler RG (2010) Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens. Cancer Epidemiol Biomark Prev 19(1):292\u2013300. doi: 10.1158\/1055-9965.EPI-09-0643","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3827_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.steroids.2015.01.007","volume":"96","author":"KM Wooding","year":"2015","unstructured":"Wooding KM, Hankin JA, Johnson CA, Chosich JD, Baek SW, Bradford AP, Murphy RC, Santoro N (2015) Measurement of estradiol, estrone, and testosterone in postmenopausal human serum by isotope dilution liquid chromatography tandem mass spectrometry without derivatization. Steroids 96:89\u201394. doi: 10.1016\/j.steroids.2015.01.007","journal-title":"Steroids"},{"key":"3827_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ab.2014.03.021","volume":"455","author":"SJ Bruce","year":"2014","unstructured":"Bruce SJ, Rey F, Beguin A, Berthod C, Werner D, Henry H (2014) Discrepancy between radioimmunoassay and high performance liquid chromatography tandem-mass spectrometry for the analysis of androstenedione. Anal Biochem 455:20\u201325. doi: 10.1016\/j.ab.2014.03.021","journal-title":"Anal Biochem"},{"key":"3827_CR22","unstructured":"Gynoflor\u00ae Vaginal Tablets [product information] (2012) Medinova Ltd (Switzerland), Zurich, April 2012"},{"key":"3827_CR23","unstructured":"Ovestin Ovula [product information] (2011) Merck & Dohme (Australia) Pty Limited, South Granvill, October 2011"},{"issue":"3","key":"3827_CR24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JOP.2011.000352","volume":"8","author":"S Wills","year":"2012","unstructured":"Wills S, Ravipati A, Venuturumilli P, Kresge C, Folkerd E, Dowsett M, Hayes DF, Decker DA (2012) Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator. J Oncol Pract 8(3):144\u2013148. doi: 10.1200\/JOP.2011.000352","journal-title":"J Oncol Pract"},{"issue":"2","key":"3827_CR25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10549-014-2930-x","volume":"145","author":"G Donders","year":"2014","unstructured":"Donders G, Neven P, Moegele M, Lintermans A, Bellen G, Prasauskas V, Grob P, Ortmann O, Buchholz S (2014) Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor((R))) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study. Breast Cancer Res Treat 145(2):371\u2013379. doi: 10.1007\/s10549-014-2930-x","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3827_CR26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/13697137.2010.529967","volume":"14","author":"G Pfeiler","year":"2011","unstructured":"Pfeiler G, Glatz C, Konigsberg R, Geisendorfer T, Fink-Retter A, Kubista E, Singer CF, Seifert M (2011) Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients. Climacteric 14(3):339\u2013344. doi: 10.3109\/13697137.2010.529967","journal-title":"Climacteric"},{"issue":"4","key":"3827_CR27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","volume":"17","author":"A Kendall","year":"2006","unstructured":"Kendall A, Dowsett M, Folkerd E, Smith I (2006) Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 17(4):584\u2013587. doi: 10.1093\/annonc\/mdj127","journal-title":"Ann Oncol"},{"issue":"9","key":"3827_CR28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/GME.0b013e318282600b","volume":"20","author":"EA Erekson","year":"2013","unstructured":"Erekson EA, Yip SO, Wedderburn TS, Martin DK, Li FY, Choi JN, Kenton KS, Fried TR (2013) The vulvovaginal symptoms questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women. Menopause 20(9):973\u2013979. doi: 10.1097\/GME.0b013e318282600b","journal-title":"Menopause"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3827-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3827-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:43:21Z","timestamp":1559234601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3827-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,13]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3827"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3827-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,13]]}}}